Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Methotrexate mainstay: ACR guidelines reaffirm old DMARD as ‘anchor drug’ in RA therapy Rob Volansky
-
- CDC advisory group says benefits of Johnson & Johnson vaccine outweigh risks Stephanie C. Viguers
- ACR: Infusions belong in a facility, not at home Jason Laday
- The COVID-19 baseball game continues: Delta comes to the plate Leonard H. Calabrese, DO
- FDA issues EUA for tocilizumab to treat patients hospitalized with COVID-19 Robert Stott
- Market gears up for biosimilar boom in 2023 as Humira exclusivity draws to a close Jason Laday
- Hooked on Rheum with Angus B. Worthing, MD Rob Volansky
- ACR, Vasculitis Foundation issue three new guidelines for 'expanded' vasculitis therapies Jason Laday
- Anakinra lowers ventilation, mortality risk in non-intubated patients with COVID-19 Jason Laday
-
- Bulk of $220 million industry payments to rheumatologists concentrated among top 6% Jason Laday
- EULAR releases first evidence-based recommendations for intra-articular therapies Jason Laday
- Home biologic infusions linked to 25% increased odds of hospital admission Jason Laday
- Infection risk lower with ustekinumab than other biologics, apremilast in PsA, psoriasis Jason Laday
- Lack of clarity in ACR, EULAR guidelines show 'urgent need' for standardized race reporting Jason Laday
- Less than 10% of Medicaid patients with lupus vaccinated against preventable disease Jason Laday
- Lupus-related neuropsychiatric events linked to active disease, corticosteroids Jason Laday
- Reduced glucocorticoid noninferior to high-dose regimen in ANCA-associated vasculitis Jason Laday
-
- Risk for COVID-19 hospitalization, death 35% higher in patients with RA Jason Laday
- Sexual, relationship dysfunction highly prevalent in noninflammatory musculoskeletal pain Jason Laday
- Sprifermin maintains long-term cartilage structural improvements in knee osteoarthritis Jason Laday
- Tofacitinib lowers risks for death, respiratory failure in COVID-19 pneumonia Jason Laday
- Step therapy legislation 'lacks teeth' to defend patient access to doctor-prescribed drugs Rob Volansky
- Governments, opioid companies reach $26B agreement Janel Miller